Skip to main content
All lobbying filings

HORIZON GOVERNMENT AFFAIRS

Lobbying for CENCORA FKA AMERISOURCEBERGEN CORPORATION · Pharmaceutical Services

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 7, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Pennsylvania

Official filing document

 Lobbyists on this filing 2
  • JOEL WHITE
    Previously held: Former Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep Chris Shay
  • BRETT MEEKS
    Previously held: Former Deputy Health Policy Director for Senate Committee on Health, Education, Labor and Pensions.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).

 Bills named in this filing 3
  • S. 2764
    Protecting Patient Access to Cancer and Complex Therapies Act of 2023
  • H.R. 5391
    Protecting Patient Access to Cancer and Complex Therapies Act
  • H.R. 5526
    Seniors’ Access to Critical Medications Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem